Q4 2017 Holdings
Filed 2018-02-09 | 30 holdings | $142.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma(ASND) | ADR | 04351P101 | $70.8M | 1,766,832 | 49.6% |
| Aclaris Therapeutics(ACRS) | Common | 00461U105 | $40.6M | 1,647,214 | 28.5% |
| Codexis, Inc.(CDXS) | Common | 192005106 | $25.5M | 3,054,825 | 17.9% |
| Aurinia Pharmaceuticals Inc.(AUPH) | Common | 05156V102 | $5.5M | 1,213,290 | 3.9% |
| Biohaven Pharmaceutical Holding Company Ltd(BHVN) | Common | G11196105 | $53.3K | 1,976,818 | 0.0% |
| Apellis Pharmaceuticals, Inc.(APLS) | Common | 03753U106 | $31.6K | 1,457,834 | 0.0% |
| Eiger BioPharmaceuticals(CLDNEUR) | Common | 28249U105 | $25.0K | 1,791,257 | 0.0% |
| Nabriva Therapeutics Plc | SHS | G63637105 | $24.4K | 4,074,190 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | Common | 00900T107 | $24.3K | 643,626 | 0.0% |
| Kala Pharmaceuticals, Inc. | Common | 483119103 | $21.4K | 1,158,911 | 0.0% |
| Advanced Accelerator Applications S.A. | ADS | 00790T100 | $20.3K | 249,241 | 0.0% |
| Strongbridge Biopharma Plc | Ordinary Shares | G85347105 | $17.8K | 2,452,397 | 0.0% |
| Verona Pharma Plc(VRNA) | ADS | 925050106 | $17.7K | 1,492,951 | 0.0% |
| Kadmon Holdings, Inc.(KDMN) | Common | 48283N106 | $12.1K | 3,333,333 | 0.0% |
| Selecta Biosciences, Inc.(SELBUSD) | Common | 816212104 | $11.0K | 1,119,189 | 0.0% |
| Amyris, Inc.(AMRSEUR) | Common | 03236M200 | $10.6K | 2,826,711 | 0.0% |
| Sierra Oncology, Inc | Common | 82640U107 | $9.1K | 2,438,270 | 0.0% |
| Soleno Therapeutics, Inc. | Common | 834203200 | $7.3K | 4,033,534 | 0.0% |
| Zai Lab LTD(ZLAB) | ADR | 98887Q104 | $6.7K | 317,567 | 0.0% |
| Regenxbio Inc.(RGNX) | Common | 75901B107 | $5.5K | 164,403 | 0.0% |
| Foamix Pharmaceuticals Ltd. | SHS | M46135105 | $5.1K | 855,000 | 0.0% |
| Zogenix, Inc. | Common | 98978L204 | $4.2K | 105,000 | 0.0% |
| Agile Therapeutics, Inc.(AGRXUSD) | Common | 00847L100 | $4.1K | 1,513,975 | 0.0% |
| KalVista Pharmaceuticals, Inc.(KALV) | Common | 483497103 | $2.9K | 300,325 | 0.0% |
| Trevena, Inc. | Common | 89532E109 | $2.8K | 1,728,000 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $2.3K | 98,511 | 0.0% |
| Sunesis Pharmaceuticals, Inc. | Common Par | 867328700 | $1.8K | 500,000 | 0.0% |
| BioPharmX Corporation | Common | 09072X101 | $1.5K | 13,799,944 | 0.0% |
| Akari Therapeutics Plc | ADR | 00972G108 | $1.5K | 345,850 | 0.0% |
| Soleno Therapeutics, Inc. | Warrant | 834203135 | $27 | 188,772 | 0.0% |